Johns Hopkins Medicine Office of Continuing Medical Education
Skip Navigation.
How ToAbout CMECME CalendarOnline/EnduringProgramsResources & DownloadsContact & Travel InformationBlog
CME Online
Forgot your password?

Not Registered yet?

Create a new account.

80024085: Buprenorphine Certification Training

November 12, 2010
  • Register
  • Send to Colleague
  • Back to List


ACCREDITATION STATEMENT

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

OTHER CREDITS

Contact Hours for Non-Physicians
The Johns Hopkins University has approved this activity for 8.25 contact hours for non-physicians.

Psychologists
The Johns Hopkins University School of Medicine is authorized by the State Board of Examiners of Psychologists as a provider of continuing education. The Johns Hopkins University School of Medicine maintains responsibility for this program. A certificate for 8025 CEUs will be awarded upon completion of this Buprenorphine certification training.

Social Workers
The Maryland Board of Social Work Examiners certifies that this program meets the criteria for 8.25 credit hours of Category 1 or 8.25 CEUs of continuing education for social workers and associates licensed in Maryland. The Johns Hopkins University School of Medicine is an approved sponsor of the Maryland Board of Social Work Examiners for continuing education credits for licensed social workers in Maryland.

DESCRIPTION
Opioid use is very prevalent in the US:
-2.5 million people have used heroin at least once in their lifetime (NHSDA, 2001)
-There are about 900,000 heroin users in the US (ONDCP, 2002)
-Lifetime use of a pain reliever for other than medical purposes: 22 million people (NHSDA, 2001)
-Use of a pain reliever for other than medical purposes in the last month: 3.5 million people (NHSDA, 2001)

The 2000 Drug Abuse Treatment Act allowed physicians in office-based settings to prescribe (and pharmacists to dispense) schedule III, IV, and V “narcotics” to treat opioid addiction. Federal legislation requires physicians to do 8 hours of buprenorphine training to be certified to provide office-based opioid treatment. After this certification training, physicians can obtain a special DEA number necessary for treatment. The activity will provide 8hours of training as required, and have forms available on the day of training for participants to request their number from the DEA. Additionally the course will focus on other professional topics such as treatment guidelines, limitations, counseling and other pharmacological and non-pharmacological services.

WHO SHOULD ATTEND
This activity is intended for Medical Students, Residents, Fellows, Attendings, and Physicians in Private Practice in the following specialties:
- Psychiatry
- Internal Medicine
- Family / Primary Care Medicine

Other Professionals (and students):
- Physician Assistants and Nurse Practitioners
- Registered Nurses
- Social Workers
- Counselors / Therapists
- Psychologists

OBJECTIVES
After attending this activity, the participant will demonstrate the ability to:
-Recognize legislative changes that have led to the availability of office-based treatment of opioid dependence in the United States
-Describe general opioid pharmacology and the pharmacology of buprenorphine and buprenorphine/naloxone
-Discuss the efficacy and safety of buprenorphine and how it compares to other pharmacologic treatments for opioid dependence
-Identify appropriate candidates and practice clinical management skills for office-based treatment of opioid dependence

PROGRAM SCHEDULE
7:OO A.M. - 5:15 P.M.
A complete program schedule will be available soon.


JOHNS HOPKINS SPEAKERS
Eric Strain, MD - Activity Director
Professor of Psychiatry and Behavioral Sciences

Amina Chaudhry, MD, MPH
Assistant Professor of Medicine

Kenneth Stoller, MD
Assistant Professor of Psychiatry and Behavioral Sciences
Johns Hopkins Bayview Medical Center

Michael Fingerhood, MD
Associate Professor of Medicine

LOCATION
Thomas B. Turner Building
The Johns Hopkins University School of Medicine
720 Rutland Avenue
Baltimore, Maryland 21205

The Turner Building is located on Rutland Avenue at Monument Street. Directions and campus parking information are available on our website under the contact and travel section at www.HopkinsCME.edu. Handicapped parking is available in the nearby Rutland Garage. Johns Hopkins is smoke-free.

FEES
REGISTRATION CUT-OFF DATE: November 7, 2010

Methods of Payment: Payment by check or credit card must accompany the registration form prior to the activity. On-site payments by credit card only. Foreign payments must be by credit card or with a U.S. Dollar World Money Order. The registration fee includes instructional materials, continental breakfast, refreshment breaks and lunch.

Registration Fee: ……..$150

Baltimore City Practicing Physicians, Attendings, Fellows, Residents, and Allied Health Professionals ……..$No Charge*

*If you practice within Baltimore City, your registration fee is complimentary. Please provide your work address and contact information so that we may verify your practice location. Please note there is a limited number of seats available, on a first-come, first-served basis, after which, the registration fee will apply.

You will receive a confirmation by e-mail if you have provided your e-mail address. Otherwise confirmation will be sent by mail. If you have not received it by November 7, 2010, call (410) 502-9634 to confirm that you are registered. Certificates of attendance will be mailed by December 27, 2010.

The Johns Hopkins University reserves the right to cancel or postpone any activity due to unforeseen circumstances. In this event, the University will refund the registration fee but is not responsible for travel expenses. Additionally, we reserve the right to change the venue to a comparable venue. Under such circumstances registrants will be notified as soon as possible.

LATE FEE AND REFUND POLICY
A $50 late fee applies to registrations received after 5:00 p.m. EST on November 7, 2010. A handling fee of $50 will be deducted for cancellation. Refund requests must be received by fax or mail by November 7, 2010. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins conference in lieu of cancellation is not possible.

PREREQUISITES
Physician registrants will need to bring with them:
- DEA Number (if applicable)
- State Medical License Number (if applicable)
- Photo ID


HOTEL AND TRAVEL INFORMATION

A listing of local hotel suggestions is available from the main page on this website (www.HopkinsCME.edu) or by calling the Office of Continuing Medical Education.

Call United Airlines at (800) 521-4041 for discounted rates and refer to Meeting ID Number 549TJ. Mileage Plus® miles are available.

ACTIVITY EVALUATION

An activity evaluation form will be available to attendees to evaluate each session and each speaker’s presentation, as well as to identify future educational needs.

OUTCOMES SURVEY

An outcomes survey will be sent to all physician attendees within three months post activity to assist us in determining what impact this activity had on the attendee’s practice.

AMERICANS WITH DISABILITIES ACT

The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.


Talks

November 12, 2010  8:00 AM to 8:15 AM

Welcome, Introduction and Conference Goals

Strain, Eric
November 12, 2010  8:15 AM to 8:45 AM

Overview of Opioid Abuse, Legislative Changes Allowing Office-Based Opioid Dependence Treatment

Strain, Eric
November 12, 2010  8:45 AM to 9:15 AM

General Opioid Pharmacology, Pharmacology of Buprenorphine and Buprenorphine/Naloxone

Strain, Eric
November 12, 2010  9:15 AM to 10:00 AM

Efficacy and Safety of Buprenorphine

Chaudhry, Amina
November 12, 2010  10:15 AM to 11:00 AM

Clinical Use of Buprenorphine

Fingerhood, Michael
November 12, 2010  11:00 AM to 11:30 AM

Overview of Methadone, Naltrexone and Clonidine

Stoller, Kenneth
November 12, 2010  11:30 AM to 12:00 PM

Patient Assessment/Selection

Stoller, Kenneth
November 12, 2010  12:00 PM to 12:45 PM

Lunch with waiver

Strain, Eric
November 12, 2010  12:45 PM to 1:15 PM

Clinical Management

Fingerhood, Michael
November 12, 2010  1:15 PM to 1:45 PM

Small Group A/Case # 1

Stoller, Kenneth
November 12, 2010  1:15 PM to 1:45 PM

Small Group B/Case #2

Chaudhry, Amina
November 12, 2010  1:15 PM to 1:45 PM

Small Group C/Case # 3

Fingerhood, Michael
November 12, 2010  1:15 PM to 1:45 PM

Small Group D/Case # 4

Strain, Eric
November 12, 2010  1:45 PM to 2:30 PM

Medical Comorbidity

Chaudhry, Amina
November 12, 2010  1:45 PM to 2:30 PM

Psychiatric Comorbidity

Stoller, Kenneth
November 12, 2010  2:45 PM to 3:15 PM

Confidentiality, Record Keeping and Office Policies and Procedures

Fingerhood, Michael
November 12, 2010  3:15 PM to 3:45 PM

Special Treatment Populations-Pain

Chaudhry, Amina
November 12, 2010  3:45 PM to 4:15 PM

Small Group A/Case # 2

Fingerhood, Michael
November 12, 2010  3:45 PM to 4:15 PM

Small Group C/Case # 2

Chaudhry, Amina
November 12, 2010  3:45 PM to 4:15 PM

Small Group D/Case # 2

Stoller, Kenneth
November 12, 2010  3:45 PM to 4:15 PM

Small GroupB /Case # 2

Strain, Eric
November 12, 2010  4:15 PM to 4:45 PM

Small Group A/Case # 3

Fingerhood, Michael
November 12, 2010  4:15 PM to 4:45 PM

Small Group B/Case # 3

Strain, Eric
November 12, 2010  4:15 PM to 4:45 PM

Small Group C/Case # 3

Stoller, Kenneth
November 12, 2010  4:15 PM to 4:45 PM

Small Group D/Case # 3

Chaudhry, Amina
November 12, 2010  4:45 PM to 5:15 PM

Wrap up, Summary, Questions and Answers and Program Evaluation

Chaudhry, Amina
November 12, 2010  4:45 PM to 5:15 PM

Wrap up, Summary, Questions and Answers and Program Evaluation

Fingerhood, Michael
November 12, 2010  4:45 PM to 5:15 PM

Wrap up, Summary, Questions and Answers and Program Evaluation

Stoller, Kenneth
November 12, 2010  4:45 PM to 5:15 PM

Wrap up, Summary, Questions and Answers and Program Evaluation

Strain, Eric

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Event Information
Johns Hopkins Broadway Research Bldg
733 N. Broadway, G01
Baltimore, MD
Directions

Registration Fee(s)

Physician – $ 150.00
ResFelAhp – $ 150.00
Physician Balto City Address – No Charge
All other Balto. City Address – No Charge

Course Director

Eric Strain

Course Co-Director

Rita Cardim

Contact Info

General Info: 410.502.9634

Mailing Address:
Johns Hopkins University School
of Medicine
Thomas B. Turner Building
720 Rutland Avenue, Room 20
Baltimore, Maryland 21205-2195

Email Us

© 2010 Johns Hopkins University
School of Medicine | Office of Continuing Medical Education
Home | Privacy Policy | Sitemap
Managed Hosting by PEER 1
HTML to PDF conversion by ABCpdf.NET